A biotech investor reportedly made $255 million in just 4 weeks on Novavax's 120% surge (NVAX)

Business Insider

Published

· *RA Capital Management, a small biotech investment firm, has made $255 million in paper profits in less than four weeks from a bet on Novavax, The Wall Street Journal reported Thursday. *
· *Shares of pharmaceutical company Novavax have surged nearly 2,300% this year. In February, the company said it was working on a vaccine...

Full Article